Speakers

Rita Zambelas

Director, Medical Science Liaison

AVROBIO

Marcus Droege

Vice President, Global Value and Access

Passage Bio

Fatima Ahmad

Vice President, Medical Affairs

Castle Creek Biosciences

Oscar Segurado

Chief Medical Officer

ASC Therapeutics

Catherine Parham

Vice President, Head of Global Medical Affairs

Astellas Gene Therapies

Karen Pinachyan

Head of Medical Affairs

CSL Behring EU

Magali Taiel

Chief Medical Officer

Gensight

Luke Rosen, kif1a

Luke Rosen

Founder

KIF1A.ORG

Kent Christopherson

Senior Director, Medical Affairs

Orchard Therapeutics

Alexis Russell

Senior Director, US Gene Therapy, Therapeutic Area Lead

PTC Therapeutics

Inha Kim

Executive Director, Medical Affairs, Northern Europe

PTC Therapeutics

Ian Winburn

Vice President, Global Medical Team Lead, Haemophilia, Endocrine In-born Errors of Metabolism and Transplantation

Pfizer

Tara Moro

Director, Gene Therapy Platform and Cross Portfolio, Rare Diseases, Global Medical Affairs

Pfizer

Stephen A. Kagan

Global Medical Lead, Gene Therapy Platform and Cross Portfolio, Rare Disease

Pfizer

Eric Depperschmidt

Ophthalmology Senior MSL Director

REGENXBIO

Kenny Robinson

Senior Director, Field Medical

REGENXBIO

Michelle Gilmor

Senior Medical Director, Rare Disease

REGENXBIO

Ramin Farhood

Vice President of Medical Affairs Practice

SSI Strategy

Sandra Casiano

Senior Medical Director

Sanofi Genzyme

Kathrin Kucharski

Senior Director Medical Managed Care

Sarepta Therapeutics

Ruth Haile-Meskale

Medical Science Liaison Lead, Gene Therapy, Hematology

Spark Therapeutics

Deborah Marsden

Global Medical Expert, Genetic/ Metabolic Disorders, Medical Affairs

Ultragenyx

Nick Li

Senior Director Market Access Lead

uniQure